Drugs / FERROUS GLUCONATE ANHYDROUS

Trials 5

20072008200920102011201220132014201520162017201820192020202120222023202420252026202720282029
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 21 trial · 1 missed
Phase 2 NCT01414075 Jul 2011 → Jan 2013 anemia Kyntra Bio Completed Missed primary
Phase 31 trial
Phase 3 NCT06248749 Feb 2024 → Dec 2028 expected anemia University of Saskatchewan Not yet recruiting No outcome recorded
Phase 43 trials
Phase 4 NCT06049693 Jan 2023 → Jan 2024 endometrial cancer National and Kapodistrian University of Athens Completed No outcome recorded
Phase 4 NCT04309669 Nov 2020 → Oct 2023 anemia Laboratoire Innotech International Completed No outcome recorded
Phase 4 NCT00248716 Feb 2007 → Apr 2009 iron deficiency anemia Soroka University Medical Center Unknown No outcome recorded
Comparator or background therapy3 trials
Phase 4 NCT06252103 Comparator May → Nov 2023 — Ain Shams University Completed No outcome recorded
Phase 4 NCT02271997 Comparator Dec 2014 → Jun 2017 disorder of iron metabolism and transport Rijnstate Hospital Completed No outcome recorded
Phase 4 NCT02228902 Comparator Aug 2014 → May 2015 disorder of mineral absorption and transport Rijnstate Hospital Completed No outcome recorded

Evidence & citations 15 cited values

Every value below carries the sentence it was read from. 9 sources stand behind the page.

FieldValueCited text
Known as FERROUS GLUCONATE ANHYDROUS ChEMBL registry synonym — accepted as the source's own label CHEMBL3991443 ↗
Known as Aktiron 35 “Groups 1 and 2 will randomly receive one of two preparations currently in use for treatment of iron deficiency in Israel (Aktiron 35 - Ferrous gluconate and Ferripel-3 - iron...” NCT00248716 ↗
Known as E-579 ChEMBL registry synonym — accepted as the source's own label CHEMBL3991443 ↗
Known as Fergon ChEMBL registry synonym — accepted as the source's own label CHEMBL3991443 ↗
Known as Ferrous gluconate “This study aims to assess the onset-of-action of oral liquid solution of ferrous gluconate, copper and manganese gluconate in adults with moderate iron deficiency anaemia.” PMID 41277915 ↗ Nov 2025
6

“ferrous fumarate or ferrous gluconate” NCT01414075 ↗

NCT02271997 ↗

NCT06049693 ↗

NCT06252103 ↗

NCT02228902 ↗

NCT00248716 ↗

Known as Ferrous gluconate dihydrate ChEMBL registry synonym — accepted as the source's own label CHEMBL3991443 ↗
Known as INS NO.579 ChEMBL registry synonym — accepted as the source's own label CHEMBL3991443 ↗
Known as INS-579 ChEMBL registry synonym — accepted as the source's own label CHEMBL3991443 ↗
Known as Iron (as ferrous gluconate) ChEMBL registry synonym — accepted as the source's own label CHEMBL3991443 ↗
Known as Iron Gluconate “Iron Sucrose, Iron Gluconate or Iron Isomaltoside (Treatment group A) versus No Iron Infusion treatment” NCT06248749 ↗
Known as Iron(ii) gluconate ChEMBL registry synonym — accepted as the source's own label CHEMBL3991443 ↗
Known as Iron(ii) gluconate, anhydrous ChEMBL registry synonym — accepted as the source's own label CHEMBL3991443 ↗
Known as Sideromal ChEMBL registry synonym — accepted as the source's own label CHEMBL3991443 ↗
Modality Small molecule — CHEMBL3991443 ↗
Route Oral “ferrous fumarate or ferrous gluconate) PO at doses containing elemental iron between 50 and 195 mg daily” NCT01414075 ↗